Byooviz (ranibizumab-nuna) is used to treat
macular degeneration. Byooviz is a biosimilar for
lucentis (ranibizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Byooviz may be covered by your Medicare or insurance plan.